Tag Archives: BTB

Linux

How the alias is working?

Leave a comment

By Vikram_Tanwar12

Iam facing some strange issue with alias. I have an alias file in which i have created lot of aliases as given below.

Code:
export BUILD_HOME=/apps/psr/build
export DB_HOME=/apps/psr/database
export LOGS_HOME=/apps/psr/logs
export BUILD_TEST=/apps/psr/build_dev/build_test
export BUILD_DEV=/apps/psr/build_dev
export BUILD_STORE=/apps/psr/store
export APP_STORE=/apps/psr/store/application
export VALIDATION_HOME=/apps/psr/validation

alias STORE="cd $APP_STORE"
alias BH="cd $BUILD_HOME"
alias BHB="cd $BUILD_HOME/bin"
alias BHW="cd $BUILD_HOME/wrappers"
alias BT="cd $BUILD_TEST"
alias BTB="cd $BUILD_TEST/bin"
alias BD="cd $BUILD_DEV"
alias VH="cd $VALIDATION_HOME"

The problem is that when i type STORE it will do its job correctly but when i type store it is not. However the same alias i have defined on other serverB where it is working in both the cases.

Also the strange thing is that when i type other alias on serverB it is not working as case insensitive. Its only working for store. I tried to google and find that we can set somthing like that

Code:
set completion-ignore-case on

but not sure if this is the correct way. Can someone please help me in this.

…read more

Source: FULL ARTICLE at The UNIX and Linux Forums

Business, Finance, Occupation & Industry

RTI Biologics Announces Positive Clinical Results for BioCleanse®-Processed BTB Allografts Used in A

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

RTI Biologics Announces Positive Clinical Results for BioCleanse ® -Processed BTB Allografts Used in ACL Reconstruction

Company to highlight implant at American Academy of Orthopaedic Surgeons’ 2013 Annual Meeting in Chicago, Ill.

ALACHUA, Fla.–(BUSINESS WIRE)– RTI Biologics Inc. (RTI) (NAS: RTIX) , a leading provider of orthopedic and other biologic implants, is pleased to announce the results of a recent randomized prospective clinical study of BioCleanse®-processed bone-patellar tendon-bone (BTB) allografts used in anterior cruciate ligament (ACL) reconstruction surgery. The study was published in the peer reviewed journal, Knee Surgery, Sports Traumatology, Arthroscopy, in December 2012.

The article compares the clinical outcomes of BTB allografts processed using RTI‘s patented BioCleanse Tissue Sterilization Process with a control group consisting of aseptically-processed allografts from the three U.S. tissue banks that provide this type of allograft. According to the American Association of Tissue Banks’ 13th edition of Standards for Tissue Banking, aseptic processing refers to the processing of tissue using methods to prevent, restrict or minimize contamination with microorganisms from the environment, processing personnel, and/or equipment. A total of 67 patients undergoing ACL reconstruction at six independent investigation sites were evaluated at six, 12 and 24 months. After randomization, 24 patients received aseptic BTB allografts and 43 patients received BioCleanse-sterilized allografts.

“These results indicate that the sterilization process, BioCleanse, did not demonstrate a statistical difference in clinical outcomes for the BTB allograft at two years,” authors find. “The BioCleanse process may provide surgeons with allografts clinically similar to aseptically-processed allograft tissue with the benefit of addressing donor-to-recipient disease.”

According to Millennium Research Group’s “U.S. Markets for Orthopedic Soft Tissue Solutions 2011″ report, more than 457,400 ACL reconstructions are performed annually in the U.S., with 21 percent of those using allograft implants. According to the authors, the use of allograft tissue in ACL reconstruction has been noted to decrease operating time, eliminate donor site morbidity and increase the tissue available for multi-ligament cases. The one disadvantage compared with autografts (the use of one’s own tissue) or metal and synthetic implants, is that disease can be transmitted as a result of an aseptically-processed allograft.

However, RTI‘s BioCleanse Tissue Sterilization Process, a patented, validated, automated process provides surgeons with a safe option for allografts. The system sterilizes tissue to SAL 10-6 using a complex, proprietary combination of mechanical and chemical processes, working in conjunction with each other. The mechanical component applies oscillating positive and negative pressure in the presence of the chemical agents …read more
Source: FULL ARTICLE at DailyFinance